期刊文献+

胰高血糖素样肽-1对肥胖2型糖尿病大鼠胰岛素敏感性的改善作用 被引量:4

Effects of glucagon-like peptide-1 improving insulin sensitivity in obese type 2 diabetic rats
下载PDF
导出
摘要 目的探讨胰高血糖素样肽(GLP)-1对肥胖2型糖尿病(T2DM)大鼠胰岛素敏感性的改善作用及机制。方法 12只6周龄雄性SD大鼠随机分为T2DM组、T2DM+GLP-1组及正常对照组(NC组)。T2DM组及T2DM+GLP-1组高脂喂养、NC组普食喂养4 w,给予T2DM组及T2DM+GLP-1组链脲佐菌素(STZ)30 mg/kg腹腔注射建立T2DM模型。受试大鼠进行高胰岛素-正葡萄糖钳夹实验。T2DM+GLP-1组大鼠在钳夹实验前30 min开始持续输注GLP-1,检测钳夹实验120 min葡萄糖输注率及0、30、60、90、120 min血清胰岛素浓度。Wester印迹法测定大鼠腓肠肌丝氨酸/苏氨酸激酶(Akt)磷酸化水平。结果与NC组比较,T2DM组钳夹实验120 min葡萄糖输注率降低(P<0.05),骨骼肌Akt磷酸化水平下降;与T2DM组比较,T2DM+GLP-1组钳夹实验120 min葡萄糖输注率增加(P<0.05),骨骼肌Akt磷酸化水平升高;各组间胰岛素浓度变化无差异(P>0.05)。结论 GLP-1可以增加平静状态T2DM大鼠葡萄糖摄取,改善骨骼肌的胰岛素敏感性,这一改善作用不依赖于胰岛素浓度的增加。 Objective To investigate the mechanism of Glucagon-like peptide(GLP)-1acted with insulin sensitivity in obese type 2 diabetic(T2DM)rats.Methods Twelve SD rats were randomized into T2DM,T2DM+GLP-1 and normal control(NC)groups.Rats of T2DM and T2DM+GLP-1 groups were fed with high fat diet for four weeks .The glucose infusion rate at 120 min and insulin concentration at 0,30, 60,90,120 min were measured by Hyperinsulinemic-euglycemic clamps.The gastrocnemius serine/threonine protein kinase(Akt)phosphoryl-ation was measured by Western blot .Results Compared with that of NC group ,the glucose infusion rate at 120 min of T2DM group was low-er〔(3.03±1.39)vs(6.52±1.73)mg? kg-1min-1,P<0.05〕,the skeletal muscle Akt phosphorylation levels of T2DM group was decreased. Compared with that of T2DM group,the glucose infusion rate at 120 min of T2DM+GLP-1 group was raised〔(6.09±1.75)vs(3.03± 1.39)mg? kg-1min-1,P<0.05〕,so do the Akt phosphorylation levels of skeletal muscle in T 2DM+GLP-1 group.There was no difference of insulin concentration among three groups .Conclusions GLP-1 increases glucose uptake and improves insulin sensitivity of skeletal muscle in tranquility status of T2DM rats.This action of GLP-1 is not with an increase of blood insulin concentration .
出处 《中国老年学杂志》 CAS CSCD 北大核心 2015年第24期6984-6987,共4页 Chinese Journal of Gerontology
基金 国家自然科学基金面上项目(81070632) 中华医学会糖尿病临床医学科研专项资金(12030490349)
关键词 胰高血糖素样肽-1 2型糖尿病大鼠 胰岛素敏感性 高胰岛素-正葡萄糖钳夹 骨骼肌 Glucagon-like peptide-1 Type 2 diabetic rats Insulin sensitivity Hyperinsulinemic-euglycemic clamps Skeletal muscle
  • 相关文献

参考文献19

  • 1Weidong Chai,Zhenhua Dong,Nasui Wang.Glucagon-Like Peptide 1 Recruits Microvasculature and Increases Glucose Use in Muscle via a Nitric Oxide-Dependent Mechanism. Diabetes . 2012
  • 2Vincent Michelle A,Clerk Lucy H,Lindner Jonathan R,Klibanov Alexander L,Clark Michael G,Rattigan Stephen,Barrett Eugene J.Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes . 2004
  • 3Dong Z,Chai W,Wang W,et al.Protein kinase a mediates glucagonlike peptide 1-induced nitric oxide production and muscle microvascular recruitment. American Journal of Physiology Endocrinology and Metabolism . 2013
  • 4Ross Renee M,Wadley Glenn D,Clark Michael G,Rattigan Stephen,McConell Glenn K.Local nitric oxide synthase inhibition reduces skeletal muscle glucose uptake but not capillary blood flow during in situ muscle contraction in rats. Diabetes . 2007
  • 5Barragán J M,Rodríguez R E,Blázquez E.Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats. The American journal of physiology . 1994
  • 6Vilsb?ll Tina.Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus. Expert opinion on investigational drugs . 2007
  • 7Cabou Cendrine,Campistron Gérard,Marsollier Nicolas,Leloup Corinne,Cruciani-Guglielmacci Celine,Pénicaud Luc,Drucker Daniel J,Magnan Christophe,Burcelin Rémy.Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes . 2008
  • 8Michell B J,Chen Zp,Tiganis T,Stapleton D,Katsis F,Power D A,Sim A T,Kemp B E.Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. Journal of Biological Chemistry . 2001
  • 9Hogan A E,Tobin A M,Ahern T,Corrigan M A,Gaoatswe G,Jackson R,O’Reilly V,Lynch L,Doherty D G,Moynagh P N,Kirby B,O’Connell J,O’Shea D.Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Diabetologia . 2011
  • 10Chai W,Zhang X,Barrett EJ,et al.Glucagon-like Peptide 1Recruits Muscle MieroVasculature and Improves Insulin’’s Metabolic Action in the Presence of Insulin Resistance. Diabetes . 2014

二级参考文献7

  • 1Nordman S, Abulaiti A, Hilding A, et al. Genetic variation of the adenylyl cyclase 3 ( AC3 ) locus and its influence on type 2 diabetes and obesity susceptibility in Swedish men[J]. Int J Obes (Lond), 2008,32 ( 3 ) :407-412.
  • 2Wang Z, Li V, Chan GC, et al. Adult type 3 adenylyl cyclase-defi- cient mice are obese[J]. PLoS One, 2009,4(9) :e6979.
  • 3Wang H, Wu M, Zhu W, et al. Evaluation of the association be- tween the AC3 genetic polymorphisms and obesity in a Chinese Han population[J]. PLoS One, 2010,5( 11 ) :e13851.
  • 4Gu HF. AC3 : a novel gene plays a role in the regulation of body weight[J]. Open Diabetes J, 2010,3(3) : 1-13.
  • 5Egan JM, Bulotta A, Hui H, et al. GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells[ J]. Diabetes Metab Res Rev, 2003,19 (2) : 115-123.
  • 6Xu G, Stoffers DA, Habener JF, et al. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats[ J]. Diabetes, 1999,48(12) :2270-2276.
  • 7Stoffers DA, Kieffer TJ, Hussain MA, et al. Insulinotropic gluca- gon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas[ J]. Diabe- tes, 2000,49 ( 5 ) :741-748.

共引文献6

同被引文献42

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部